GET THE APP

Hydrazone-hydrazide derivatives as potential antineoplastic agents by inhibiting the interaction between nucleic acids and protein hnRNP
..

Medicinal Chemistry

ISSN: 2161-0444

Open Access

Hydrazone-hydrazide derivatives as potential antineoplastic agents by inhibiting the interaction between nucleic acids and protein hnRNP


3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing

December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Gilberto Lucio Benedito de Aquino, Wanderson Costa de Souza, Renata Nishida Goto, Andria Machado Leopoldino, Vncius Barreto da Silva and Giuliana Muniz Vila Verde Safadi

Accepted Abstracts: Med Chem

Abstract :

Cancer (neoplasia) is defined as a chronic multifactorial disease characterized by proliferation of transformed cells. From the molecular analysis of healthy and neoplastic tissues at different stages, it is possible to identify markers related to the stages of cancer, allowing choices more appropriate and effective therapies. The hnRNPK protein was identified as one of those markers in various malignancies. The hnRNPK protein has three KH domains, which are responsible for its binding with DNA and RNA. 15 hydrazide-hydrazonederivatives synthesized in our laboratory had their ability to inhibit proteinnucleic acid interaction. One of these compounds showed the ability to prevent the interaction and study of molecular docking between the hnRNPK protein and hyrazide-hydrazone derivative which provide important details of the modes of binding of the compound in the binding site domain KH3 used for docking.

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 5231

Medicinal Chemistry received 5231 citations as per Google Scholar report

Medicinal Chemistry peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward